| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Friedreich Ataxia | 29 | 2022 | 44 | 7.170 |
Why?
|
| Iron-Binding Proteins | 23 | 2022 | 35 | 4.480 |
Why?
|
| Trinucleotide Repeat Expansion | 19 | 2022 | 32 | 4.050 |
Why?
|
| Trinucleotide Repeats | 11 | 2015 | 14 | 1.860 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 145 | 1.830 |
Why?
|
| Gene Silencing | 4 | 2021 | 64 | 1.680 |
Why?
|
| DNA Replication | 6 | 2010 | 49 | 1.320 |
Why?
|
| Promoter Regions, Genetic | 8 | 2016 | 331 | 1.210 |
Why?
|
| DNA Methylation | 3 | 2022 | 149 | 0.950 |
Why?
|
| Alleles | 10 | 2021 | 345 | 0.880 |
Why?
|
| Phenotype | 5 | 2021 | 667 | 0.810 |
Why?
|
| Mutation | 10 | 2012 | 818 | 0.760 |
Why?
|
| Transcription, Genetic | 6 | 2016 | 400 | 0.750 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 79 | 0.710 |
Why?
|
| Introns | 7 | 2015 | 41 | 0.690 |
Why?
|
| Ganglia, Spinal | 3 | 2012 | 25 | 0.650 |
Why?
|
| Humans | 46 | 2022 | 27119 | 0.620 |
Why?
|
| Nucleosomes | 2 | 2016 | 18 | 0.590 |
Why?
|
| Microsatellite Instability | 2 | 2007 | 10 | 0.580 |
Why?
|
| Sequence Deletion | 6 | 2007 | 65 | 0.570 |
Why?
|
| Escherichia coli | 3 | 2008 | 330 | 0.540 |
Why?
|
| Genome, Human | 3 | 2006 | 67 | 0.540 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 26 | 0.510 |
Why?
|
| DNA | 9 | 2022 | 365 | 0.490 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2014 | 1 | 0.460 |
Why?
|
| Transcription Initiation Site | 1 | 2014 | 9 | 0.460 |
Why?
|
| Genomic Instability | 3 | 2012 | 33 | 0.450 |
Why?
|
| DNA Mismatch Repair | 2 | 2012 | 12 | 0.420 |
Why?
|
| Factor VIII | 5 | 1995 | 19 | 0.410 |
Why?
|
| DNA Repair Enzymes | 1 | 2012 | 9 | 0.410 |
Why?
|
| Adenosine Triphosphatases | 1 | 2012 | 48 | 0.400 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 5 | 1999 | 27 | 0.390 |
Why?
|
| DNA-Binding Proteins | 2 | 2012 | 481 | 0.370 |
Why?
|
| Cerebellum | 2 | 2012 | 40 | 0.370 |
Why?
|
| DNA Sequence, Unstable | 1 | 2010 | 1 | 0.360 |
Why?
|
| Spinocerebellar Ataxias | 2 | 2007 | 26 | 0.350 |
Why?
|
| Animals | 12 | 2022 | 10080 | 0.350 |
Why?
|
| Base Sequence | 14 | 2008 | 573 | 0.340 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2010 | 9 | 0.340 |
Why?
|
| Genetic Testing | 1 | 2010 | 64 | 0.330 |
Why?
|
| Male | 21 | 2021 | 13022 | 0.320 |
Why?
|
| Repressor Proteins | 1 | 2009 | 114 | 0.310 |
Why?
|
| Female | 20 | 2021 | 14635 | 0.300 |
Why?
|
| Mice | 7 | 2022 | 4473 | 0.300 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2007 | 24 | 0.290 |
Why?
|
| Child | 6 | 2021 | 2160 | 0.290 |
Why?
|
| Anticipation, Genetic | 1 | 2007 | 3 | 0.290 |
Why?
|
| TATA-Box Binding Protein | 1 | 2007 | 3 | 0.290 |
Why?
|
| DNA Repair | 1 | 2007 | 81 | 0.280 |
Why?
|
| Adolescent | 5 | 2021 | 2988 | 0.280 |
Why?
|
| DNA, Bacterial | 1 | 2008 | 302 | 0.280 |
Why?
|
| Genetic Carrier Screening | 3 | 2004 | 10 | 0.280 |
Why?
|
| Polymerase Chain Reaction | 9 | 2004 | 262 | 0.270 |
Why?
|
| Mice, Transgenic | 4 | 2015 | 489 | 0.270 |
Why?
|
| Adult | 8 | 2021 | 7492 | 0.250 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2016 | 20 | 0.240 |
Why?
|
| Cognition Disorders | 1 | 2006 | 181 | 0.240 |
Why?
|
| Nerve Tissue Proteins | 2 | 2007 | 151 | 0.230 |
Why?
|
| Genetic Variation | 1 | 2005 | 229 | 0.230 |
Why?
|
| Alu Elements | 1 | 2004 | 2 | 0.230 |
Why?
|
| Rec A Recombinases | 3 | 2008 | 7 | 0.230 |
Why?
|
| Inheritance Patterns | 1 | 2004 | 3 | 0.230 |
Why?
|
| Molecular Biology | 1 | 2004 | 16 | 0.220 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2004 | 20 | 0.220 |
Why?
|
| RNA Stability | 2 | 2016 | 26 | 0.220 |
Why?
|
| Mexico | 4 | 2007 | 88 | 0.210 |
Why?
|
| Cell Line | 2 | 2016 | 681 | 0.210 |
Why?
|
| Hemophilia A | 4 | 1995 | 15 | 0.210 |
Why?
|
| Infant | 2 | 2021 | 966 | 0.210 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2004 | 31 | 0.210 |
Why?
|
| Child, Preschool | 2 | 2021 | 1100 | 0.210 |
Why?
|
| Fibroblasts | 3 | 2015 | 153 | 0.210 |
Why?
|
| Gene Frequency | 5 | 2007 | 182 | 0.200 |
Why?
|
| Heterochromatin | 2 | 2014 | 7 | 0.200 |
Why?
|
| Molecular Sequence Data | 11 | 2007 | 1037 | 0.190 |
Why?
|
| Genotype | 3 | 2014 | 443 | 0.190 |
Why?
|
| Protein Isoforms | 1 | 2022 | 118 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 655 | 0.190 |
Why?
|
| Neoplasms | 1 | 2010 | 766 | 0.180 |
Why?
|
| Age of Onset | 3 | 2007 | 68 | 0.180 |
Why?
|
| Middle Aged | 6 | 2010 | 6900 | 0.180 |
Why?
|
| Simian virus 40 | 3 | 2010 | 7 | 0.170 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 440 | 0.170 |
Why?
|
| Replication Origin | 2 | 2010 | 4 | 0.160 |
Why?
|
| COS Cells | 2 | 2010 | 48 | 0.160 |
Why?
|
| Heterozygote | 3 | 1997 | 64 | 0.160 |
Why?
|
| Pedigree | 6 | 2007 | 153 | 0.150 |
Why?
|
| Cells, Cultured | 3 | 2015 | 976 | 0.150 |
Why?
|
| Myelin Proteins | 3 | 2001 | 13 | 0.140 |
Why?
|
| Escherichia coli Proteins | 2 | 2008 | 113 | 0.140 |
Why?
|
| DNA Mutational Analysis | 3 | 2006 | 90 | 0.140 |
Why?
|
| RNA, Messenger | 3 | 2010 | 648 | 0.130 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 1405 | 0.130 |
Why?
|
| CpG Islands | 1 | 2015 | 23 | 0.130 |
Why?
|
| Age Factors | 3 | 2007 | 721 | 0.120 |
Why?
|
| Protein Binding | 2 | 2016 | 636 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 129 | 0.120 |
Why?
|
| Polymorphism, Genetic | 2 | 2007 | 163 | 0.120 |
Why?
|
| RNA Splicing | 1 | 1994 | 9 | 0.110 |
Why?
|
| Linear Models | 1 | 2014 | 201 | 0.110 |
Why?
|
| Young Adult | 1 | 2021 | 2626 | 0.110 |
Why?
|
| Organizations | 1 | 2013 | 4 | 0.110 |
Why?
|
| Financial Management | 1 | 2013 | 6 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2006 | 863 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2013 | 12 | 0.110 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 2012 | 2 | 0.100 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2012 | 2 | 0.100 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 1 | 2012 | 6 | 0.100 |
Why?
|
| Disease Progression | 2 | 2007 | 458 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2013 | 93 | 0.100 |
Why?
|
| Genetic Counseling | 2 | 2010 | 14 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2010 | 17 | 0.090 |
Why?
|
| CCCTC-Binding Factor | 1 | 2009 | 2 | 0.080 |
Why?
|
| 5' Untranslated Regions | 1 | 2009 | 9 | 0.080 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2009 | 22 | 0.080 |
Why?
|
| Zinc Fingers | 1 | 2009 | 26 | 0.080 |
Why?
|
| Germ-Line Mutation | 1 | 2010 | 29 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 34 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 70 | 0.080 |
Why?
|
| INDEL Mutation | 1 | 2008 | 7 | 0.080 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 242 | 0.080 |
Why?
|
| Anxiety | 1 | 2010 | 140 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 2 | 2007 | 365 | 0.070 |
Why?
|
| Dental Caries | 1 | 2007 | 21 | 0.070 |
Why?
|
| Exodeoxyribonuclease V | 1 | 2007 | 3 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 1998 | 15 | 0.070 |
Why?
|
| Depression | 1 | 2010 | 212 | 0.070 |
Why?
|
| Genes, Dominant | 1 | 2007 | 35 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2007 | 76 | 0.070 |
Why?
|
| Embryonic Development | 1 | 2007 | 21 | 0.070 |
Why?
|
| Calcium Channels | 1 | 2007 | 32 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 988 | 0.070 |
Why?
|
| Myelin Sheath | 3 | 2001 | 25 | 0.070 |
Why?
|
| Cerebellar Ataxia | 1 | 2006 | 2 | 0.070 |
Why?
|
| Homozygote | 2 | 2004 | 36 | 0.070 |
Why?
|
| Genes, Recessive | 2 | 2004 | 21 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 1997 | 675 | 0.070 |
Why?
|
| Genetic Therapy | 3 | 2001 | 116 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 325 | 0.060 |
Why?
|
| Haplotypes | 2 | 2004 | 279 | 0.060 |
Why?
|
| Models, Genetic | 2 | 2004 | 123 | 0.060 |
Why?
|
| Genomics | 1 | 2006 | 116 | 0.060 |
Why?
|
| Species Specificity | 1 | 2005 | 187 | 0.060 |
Why?
|
| Peptides | 1 | 2007 | 280 | 0.060 |
Why?
|
| African Americans | 1 | 2007 | 350 | 0.060 |
Why?
|
| Templates, Genetic | 1 | 2004 | 9 | 0.060 |
Why?
|
| Linkage Disequilibrium | 1 | 2004 | 107 | 0.060 |
Why?
|
| Genetics, Population | 1 | 2004 | 72 | 0.060 |
Why?
|
| Blotting, Southern | 2 | 2004 | 26 | 0.060 |
Why?
|
| Genomic Imprinting | 1 | 2004 | 4 | 0.060 |
Why?
|
| Sex Factors | 2 | 2004 | 452 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2001 | 24 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 80 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 474 | 0.050 |
Why?
|
| Databases, Factual | 2 | 1994 | 251 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 161 | 0.050 |
Why?
|
| Time Factors | 1 | 2007 | 1570 | 0.050 |
Why?
|
| DNA Primers | 3 | 2004 | 143 | 0.050 |
Why?
|
| Chromosome Inversion | 3 | 1997 | 3 | 0.050 |
Why?
|
| Lymphocytes | 2 | 1999 | 82 | 0.050 |
Why?
|
| Indians, North American | 1 | 2006 | 514 | 0.050 |
Why?
|
| Leukocytes | 1 | 2002 | 68 | 0.050 |
Why?
|
| Genes, Regulator | 1 | 2001 | 11 | 0.050 |
Why?
|
| Algorithms | 1 | 2004 | 422 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 1 | 2001 | 90 | 0.050 |
Why?
|
| Myelin P0 Protein | 1 | 2000 | 1 | 0.040 |
Why?
|
| Schwann Cells | 1 | 2000 | 3 | 0.040 |
Why?
|
| Peripheral Nervous System | 1 | 2000 | 2 | 0.040 |
Why?
|
| Poly A | 1 | 1999 | 5 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2000 | 114 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 1999 | 205 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 1996 | 111 | 0.040 |
Why?
|
| Sural Nerve | 1 | 1998 | 11 | 0.040 |
Why?
|
| Mosaicism | 1 | 1998 | 12 | 0.040 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1998 | 2 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 205 | 0.040 |
Why?
|
| Keratinocytes | 2 | 1995 | 32 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 1997 | 54 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1997 | 130 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 1997 | 34 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 1997 | 130 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1996 | 7 | 0.030 |
Why?
|
| Keratins | 1 | 1995 | 10 | 0.030 |
Why?
|
| Hemophilia B | 1 | 1995 | 3 | 0.030 |
Why?
|
| Factor IX | 1 | 1995 | 4 | 0.030 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1994 | 6 | 0.030 |
Why?
|
| Exons | 1 | 1994 | 41 | 0.030 |
Why?
|
| Genes | 1 | 1994 | 35 | 0.030 |
Why?
|
| Proteins | 1 | 1996 | 245 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1994 | 66 | 0.030 |
Why?
|
| United States Government Agencies | 1 | 2013 | 1 | 0.030 |
Why?
|
| Health Resources | 1 | 2013 | 18 | 0.030 |
Why?
|
| Canada | 1 | 2013 | 58 | 0.030 |
Why?
|
| United Kingdom | 1 | 2013 | 70 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 589 | 0.020 |
Why?
|
| Proline-Rich Protein Domains | 1 | 2007 | 1 | 0.020 |
Why?
|
| Salivary Proline-Rich Proteins | 1 | 2007 | 1 | 0.020 |
Why?
|
| DMF Index | 1 | 2007 | 4 | 0.020 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2007 | 6 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2007 | 81 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 144 | 0.020 |
Why?
|
| Saliva | 1 | 2007 | 94 | 0.020 |
Why?
|
| Streptococcus mutans | 1 | 2007 | 38 | 0.020 |
Why?
|
| Social Class | 1 | 2007 | 78 | 0.020 |
Why?
|
| United States | 1 | 2013 | 2060 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2007 | 705 | 0.020 |
Why?
|
| Point Mutation | 2 | 1996 | 60 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 245 | 0.020 |
Why?
|
| Genetic Linkage | 2 | 1994 | 92 | 0.010 |
Why?
|
| AT Rich Sequence | 1 | 2004 | 1 | 0.010 |
Why?
|
| Microscopy, Atomic Force | 1 | 2004 | 19 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 262 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2001 | 47 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 2001 | 5 | 0.010 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2001 | 2 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2001 | 25 | 0.010 |
Why?
|
| Manganese | 1 | 2001 | 22 | 0.010 |
Why?
|
| Nucleotides | 1 | 2001 | 20 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2001 | 62 | 0.010 |
Why?
|
| Base Pairing | 1 | 2001 | 25 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2001 | 50 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 129 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2001 | 107 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 310 | 0.010 |
Why?
|
| Transfection | 1 | 2001 | 313 | 0.010 |
Why?
|
| Binding Sites | 1 | 2001 | 341 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2001 | 241 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2000 | 18 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 508 | 0.010 |
Why?
|
| Peripheral Nerves | 1 | 1998 | 4 | 0.010 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1998 | 22 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2001 | 626 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1998 | 150 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2001 | 512 | 0.010 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 1997 | 3 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1997 | 5 | 0.010 |
Why?
|
| Biopsy | 1 | 1998 | 201 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 72 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 1998 | 81 | 0.010 |
Why?
|
| Rats | 1 | 2000 | 1554 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1995 | 11 | 0.010 |
Why?
|
| Epidermis | 1 | 1995 | 11 | 0.010 |
Why?
|
| Sex Ratio | 1 | 1994 | 1 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 1994 | 13 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 1994 | 32 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1995 | 191 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 229 | 0.010 |
Why?
|
| Methods | 1 | 1994 | 27 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1994 | 116 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1994 | 24 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1997 | 846 | 0.010 |
Why?
|
| Gene Expression | 1 | 1995 | 408 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 1995 | 1496 | 0.010 |
Why?
|